Contribution of Vaccination to the Reduction of Infectious Mortality in Ukraine in the Second Half of the 20 and Early 21 Century: A Comparative Population-Based Study of the Dynamics and Structure of Infectious Mortality and Incidence
Overview
Microbiology
Affiliations
Our work presents an epidemiological analysis of the dynamics and structure of the annual indicators such as Cumulative Incidence, Mortality Rate (MR), and Case Fatality Rate for infections preventable by vaccines (vaccine-preventable infections-VPIs) in Ukraine between 1944 and 2015 compared to the same indicators for infections not preventable by vaccines (nonvaccine-preventable infections-non-VPIs). In 1965, the proportion of all infectious diseases in the context of mortality (7.47%), and especially of VPI (3.77%), including those registered among children aged 0-14 years (2.12%), testifies to the low profile of infectious diseases by the time of routine vaccination introduction. The analyses of these particular data are important with respect to the role of vaccination programs in reducing not only the total infectious mortality but also mortality related to VPIs in the twentieth century. Interestingly, in Ukraine between 1965 and 2015, similar rates of mortality reduction were observed in both the total population (1.6-2.6 times) and in children under 14 (15.2-20.4 times) for both VPIs and non-VPIs. During the 1944-2015 period in Ukraine, the reduction of MR of VPI (tuberculosis, diphtheria, tetanus, pertussis, poliomyelitis, measles, and hepatitis B) varied greatly, ranging from 40.5 times (tetanus) to 1,061.1 times (measles), but in general, the reduction incidence rate of VPI was significantly lower ranging from 42.4 times (measles) to 471.1 times (diphtheria). The ratio of incidence and mortality reduction in percent shows the contribution of vaccination to the mortality reduction for various infections during 1944-2015. This ratio ranged from 0% (tuberculosis) to 84.9% (tetanus), provided that the reduction of the VPI incidence 100% depends on vaccine effects. Thus, we can assume that the observed reduction in mortality for some VPIs was, in part, caused by factors not associated with vaccines.
In Silico Subtractive Proteome Analysis to Design Multi-Epitope-Based Subunit Vaccine against .
AlMalki F J Microbiol Biotechnol. 2025; 35:e2410015.
PMID: 39809513 PMC: 11813342. DOI: 10.4014/jmb.2410.10015.
Exploring influential factors in childhood vaccine delays in Riyadh, Saudi Arabia.
Basham K, Al Mutairi F, Baw B, Al Said L J Family Med Prim Care. 2024; 13(8):3165-3172.
PMID: 39228617 PMC: 11368322. DOI: 10.4103/jfmpc.jfmpc_95_24.
Ghaffar S, Tahir H, Muhammad S, Shahid M, Naqqash T, Faisal M Front Immunol. 2024; 15:1380732.
PMID: 38690283 PMC: 11058264. DOI: 10.3389/fimmu.2024.1380732.
Ludvigsson J, Loboda A Acta Paediatr. 2022; 111(7):1341-1353.
PMID: 35466444 PMC: 9324783. DOI: 10.1111/apa.16370.
Evolving measles status and immunization policy development in six European countries.
Vojtek I, Larson H, Plotkin S, Van Damme P Hum Vaccin Immunother. 2022; 18(1):2031776.
PMID: 35180372 PMC: 9009904. DOI: 10.1080/21645515.2022.2031776.